Enanta Pharmaceuticals: Fiscal 4Q Earnings Snapshot

November 26, 2018

WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Monday reported fiscal fourth-quarter net income of $27.4 million.

The Watertown, Massachusetts-based company said it had profit of $1.30 per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.24 per share.

The biotechnology company posted revenue of $67.2 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $69.1 million.

For the year, the company reported profit of $72 million, or $3.48 per share. Revenue was reported as $206.6 million.

Enanta Pharmaceuticals shares have climbed 40 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $82.06, a climb of 71 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENTA at https://www.zacks.com/ap/ENTA

Update hourly